Company / Net Income
Maze Therapeutics, Inc. Net Income History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$131.1M
FY2025
5-year range
-$131.1M / -$131.1M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#122 of 216
Health Care
What the data says
At -$131M, Maze Therapeutics, Inc.'s net income ranks #122 of 216 in the Health Care sector.
Based on SEC 10-K filings.
-$131M in FY2025.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#122 of 216 in Health CareTop 56% of 216This company -$131.1M Sector average $454.3M
▼
-128.9% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$131.1M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026